Evidence map›Paper›PMID 42652965›Full record

ArticleLife (Basel, Switzerland)2026

pK Values of the Cofactor Tune the Redox Regime of Flavoenzymes.

Wolfgang Nitschke, Simon Duval, Kilian Zuchan, Jostin Monge-Ruiz, Frauke Baymann, Barbara Schoepp-Cothenet

Abstract read
In one paragraph

Article in Life (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Wolfgang NitschkeBIP (UMR 7281), CNRS, Aix-Marseille-University, 13009 Marseille, France.ORCID 0000-0003-2084-3032
Simon DuvalBIP (UMR 7281), CNRS, Aix-Marseille-University, 13009 Marseille, France.ORCID 0000-0003-2946-6771
Kilian ZuchanDepartment of Inorganic and Analytical Chemistry, University of Geneva, 1211 Geneva, Switzerland.ORCID 0000-0002-2041-8944
Jostin Monge-RuizBIP (UMR 7281), CNRS, Aix-Marseille-University, 13009 Marseille, France.
Frauke BaymannBIP (UMR 7281), CNRS, Aix-Marseille-University, 13009 Marseille, France.
Barbara Schoepp-CothenetBIP (UMR 7281), CNRS, Aix-Marseille-University, 13009 Marseille, France.ORCID 0000-0002-6820-4478

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Across the diverse family of flavoenzymes, the isoalloxazine cofactor was found to display extremely diverse redox properties, both with respect to the absolute value of the potential regime wherein it operates and to its redox cooperativity, that is, the relative positioning of its individual 1-electron transitions. Taking together electrochemical data and 3D structural information reported for selected representatives of the flavoenzyme family, we assessed the contribution of pK value modifications at the three protonatable nitrogens of the isoalloxazine moiety. While the absolute value of the redox regime appears only weakly dependent on such pK modifications, the diversity of redox cooperativity is readily rationalized by (protein-induced) stabilization/destabilization of the proton primarily on N5 and to lesser degrees on N1 and N3. The mathematical formalism underlying the interdependence of pK values and redox midpoint potentials is subsequently extended to representatives of the family featuring extremely positive redox cooperativity (i.e., the electron bi/confurcating flavoenzymes). Observed structural idiosyncrasies of these cases were found to rationalize the extremely strong inversion (ΔE ≪ -800 mV) of 1-electron midpoint potentials in the framework of this formalism.

Indexed as

electron bi/confurcationETFflavodoxinflavoenzymesFNRhydrogen bondNdh-2pK valuesredox cooperativitySQR

Identifiers

PMID42652965
PMCPMC13514486

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.